HPV and CSC in HNSCC cisplatin resistance

Frontiers in Bioscience - Elite

Volumn 7E, Issue 1, 2015, Pages 66-76

  Modur, Vishnu ^a   Robbins, K Thomas ^a   Rao, Krishna ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer stem cells; CD44; Cisplatin; EGFR; Head and neck cancer; HNSCC; HPV; Review

Indexed keywords

CISPLATIN; HERMES ANTIGEN; VASCULOTROPIN RECEPTOR; CD44V ANTIGEN; EPIDERMAL GROWTH FACTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STEM CELL; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; OROPHARYNX CARCINOMA; TREATMENT RESPONSE; WART VIRUS; ADULT STEM CELL; ANTIBODY PRODUCTION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RESISTANCE; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CHEMORADIOTHERAPY; CLINICAL EVALUATION; DISEASE ASSOCIATION; MOLECULAR BIOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; REVIEW; RISK FACTOR;

HUMAN PAPILLOMAVIRUS;

EID: 84918564953     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/E717     Document Type: Article

References (54)

1. Lorch, J.H, O. Goloubeva, Robert I.H, Kevin C, Nicholas S, R. Tishler, M. Tan, J. Fasciano, D.E. Sammartino, and M. R. Posner. "Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial." The lancet oncology 12, 153-159 (2011) DOI: 10.1016/S1470-2045(10)70279-5
2. Yang, Z.; Faustino, P.J.; Andrews, P.A.; Monastra, R.; Rasmussen, A.A.; Ellison, C.D.; Cullen, K.J. Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines Cancer Chemother Pharmacol 46, 255-262 (2000) DOI: 10.1007/s002800000167 PMid:11052622
3. Cullen, K.J.; Newkirk, K.A.; Schumaker, L.M.; Aldosari, N.; Rone, J.D.; Haddad, B.R. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors Cancer Res 63, 8097-8102 (2003) PMid:14678959 NO DOI found
4. Jacobs, C., Lyman, G., Velez-Garcia, E., Sridhar, K. S., Knight, W., Hochster, H.,Goodnough, L. T., Mortimer, J. E., Einhorn, L. H., Schacter, L., Cherng, N., Dalton, T., Burroughs, J., and Rozencweig, M. A Phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol 10, 257-263 (1992) PMid:1732427 NO DOI found
5. Kelland, L. The resurgence of platinumbased cancer chemotherapy Nat Rev Cancer. 7, 573-584 (2007) DOI: 10.1038/nrc2167 PMid:17625587
6. Sherman, S.E.; Gibson, D.; Wang, A.H.; Lippard, S.J. X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-(Pt(NH3)2(d(pGpG))) Science 230, 412-417 (1985) DOI: 10.1126/science.4048939 PMid:4048939
7. Kerr, J.F.; Winterford, C.M.; Harmon, B.V. Apoptosis - Its significance in cancer and cancer therapy Cancer 73, 2013-2026 (1994) DOI: 10.1002/1097-0142(19940415)73:8〈2013::AID-CNCR2820730802〉3.0.CO;2-J
8. Eastman, A. Activation of programmed cell death by anticancer agents: cisplatin as a model system Cancer Cells 2, 275-280 (1990) PMid:2223389 NO DOI found
9. Sedletska, Y.; Giraud-Panis, M.J.; Malinge, J.M. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways Curr Med Chem Anticancer Agents 5, 251-265 (2005) DOI: 10.2174/1568011053765967 PMid:15992353
10. Byfield, J.E.; Calabro-Jones, P.M. Carrierdependent and carrier-independent transport of anti-cancer alkylating agents Nature 294, 281-283 (1981) DOI: 10.1038/294281a0 PMid:6975441
11. Andrews, P.A.; Mann, S.C.; Huynh, H.H.; Albright, K.D. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cisdiamminedichloroplatinum(II) in human ovarian carcinoma cells Cancer Res 51, 3677-3681 (1991) PMid:1648442 NO DOI found
12. Hall, M.D.; Okabe, M.; Shen, D.W.; Liang, X.J.; Gottesman, M.M. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy Annu Rev Pharmacol Toxicol 48, 495-535 (2008) DOI: 10.1146/annurev.pharmtox.48.080907.180426 PMid:17937596
13. Safaei, R.; Howell, S.B. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs Crit Rev Oncol Hematol 53, 13-23 (2005) DOI: 10.1016/j.critrevonc.2004.09.007 PMid:15607932
14. D'Souza, G.; Agrawal, Y.; Halpern, J.; Bodison, S.; Gillison, M.L. Oral sexual behaviors associated with prevalent oral human papillomavirus infection J Infect Dis 199, 1263-1269 (2009) DOI: 10.1086/597755 PMid:19320589
15. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100, 407-420 (2008) DOI: 10.1093/jnci/djn025 PMid:18334711
16. Munger, K. The role of human papillomaviruses in human cancers Front Biosci 7, 641-649 (2002) DOI: 10.2741/munger
17. Dell, G.; Gaston, K. Human papillomaviruses and their role in cervical cancer Cell Mol Life Sci 58, 1923-1942 (2001) DOI: 10.1007/PL00000827 PMid:11766888
18. Lewis, J.S., Jr.; Chernock, R.D.; Ma, X.J.; Flanagan, J.J.; Luo, Y.; Gao, G.; Wang, X.; El-Mofty, S.K. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status Mod Pathol 25, 1212-1220 (2012) DOI: 10.1038/modpathol.2012.79 PMid:22596101
19. Schwartz, S.M.; Daling, J.R.; Doody, D.R.; Wipf, G.C.; Carter, J.J.; Madeleine, M.M.; Mao, E.J.; Fitzgibbons, E.D.; Huang, S.; Beckmann, A.M.; McDougall, J.K.; Galloway, D.A. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection J Natl Cancer Inst 90, 1626-1636 (1998) DOI: 10.1093/jnci/90.21.1626 PMid:9811312
20. Smith, E.M.; Hoffman, H.T.; Summersgill, K.S.; Kirchner, H.L.; Turek, L.P.; Haugen, T.H. Human papillomavirus and risk of oral cancer Laryngoscope 108, 1098-1103 (1998) DOI: 10.1097/00005537-199807000-00027 PMid:9665264
21. Maden, C.; Beckmann, A.M.; Thomas, D.B.; McKnight, B.; Sherman, K.J.; Ashley, R.L.; Corey, L.; Daling, J.R. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men Am J Epidemiol 135, 1093-1102 (1992) PMid:1321561 NO DOI found
22. Mork, J.; Lie, A.K.; Glattre,E.; Hallmans, G.; Jellum, E.; Koskela, P.; Moller, B.; Pukkala, E.; Schiller, J.T.; Youngman, L.; Lehtinen, M.; Dillner, J. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck N Engl J Med 344,1125-1131 (2001) DOI: 10.1056/NEJM200104123441503 PMid:11297703
23. Conway, M.J.; Meyers, C. Replication and assembly of human papillomaviruses J Dent Res 8, 307-317 (2009) DOI: 10.1177/0022034509333446 PMid:19407149 PMCid:PMC3317948
24. Doorbar, J. The papillomavirus life cycle J Clin Virol 32, 7-15 (2005) DOI: 10.1016/j.jcv.2004.12.006 PMid:15753007
25. Longworth, M.S.; Laimins, L.A. Pathogenesis of human papillomaviruses in differentiating epithelia Microbiol Mol Biol Rev 68, 362-372 (2004) DOI: 10.1128/MMBR.68.2.362-372.2004 PMid:15187189 PMCid:PMC419925
26. Feller, L.; Khammissa, R.A.; Wood, N.H.; Lemmer, J. Epithelial maturation and molecular biology of oral HPV Infect Agent Cancer 4, 16 (2009) DOI: 10.1186/1750-9378-4-16 PMid:19930727 PMCid:PMC2788520
27. Weinberger, P.M.; Yu, Z.; Haffty, B.G.; Kowalski, D.; Harigopal, M.; Brandsma, J.; Sasaki, C.; Joe, J.; Camp, R.L.; Rimm, D.L.; Psyrri, A. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24, 736-747 (2006) DOI: 10.1200/JCO.2004.00.3335 PMid:16401683
28. Munger, K.; Baldwin, A.; Edwards, K.M.; Hayakawa, H.; Nguyen, C.L.; Owens, M.; Grace, M.; Huh, K. Mechanisms of human papillomavirus-induced oncogenesis J Virol 78, 11451-11460 (2004) DOI: 10.1128/JVI.78.21.11451-11460.2004 PMid:15479788 PMCid:PMC523272
29. Ang, K.K.; Harris, J.; Wheeler, R.; Weber, R.; Rosenthal, D.I.; Nguyen-Tan, P.F.; Westra, W.H.; Chung, C.H.; Jordan, R.C.; Lu, C.; Kim, H.; Axelrod, R.; Silverman, C.C.; Redmond, K.P.; Gillison, M.L. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363, 24-35 (2010) DOI: 10.1056/NEJMoa0912217 PMid:20530316 PMCid:PMC2943767
30. Kumar, B.; Cordell, K.G.; Lee, J.S.; Worden, F.P.; Prince, M.E.; Tran, H.H.; Wolf, G.T.; Urba, S.G.; Chepeha, D.B.; Teknos, T.N.; Eisbruch, A.; Tsien,C.I.; Taylor, J.M.; D'Silva, N.J.; Yang, K.; Kurnit, D.M.; Bauer, J.A.; Bradford, C.R.; Carey, T.E. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26, 3128-3137 (2008) DOI: 10.1200/JCO.2007.12.7662 PMid:18474878 PMCid:PMC2744895
31. Laimer, K.; Spizzo, G.; Gastl, G.; Obrist, P.; Brunhuber, T.; Fong, D.; Barbieri, V.; Jank, S.; Doppler, W.; Rasse, M.; Norer, B. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis Oral Oncol 43, 193-198 (2007) DOI: 10.1016/j.oraloncology.2006.02.009 PMid:16854613
32. Psyrri, A.; Gouveris, P.; Vermorken, J.B. Human papillomavirus-related head and neck tumors: clinical and research implication Curr Opin Oncol 21, 201-205 (2009) DOI: 10.1097/CCO.0b013e328329ab64 PMid:19370803
33. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells Nature 414, 105-111 (2001) DOI: 10.1038/35102167 PMid:11689955
34. Michor, F.; Hughes, T.P.; Iwasa, Y.; Branford, S.; Shah, N.P.; Sawyers, C.L.; Nowak, M.A. Dynamics of chronic myeloid leukemia Nature 435, 1267-1270 (2005) DOI: 10.1038/nature03669 PMid:15988530
35. Wang, S.J.; Bourguignon, L.Y. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer Arch Otolaryngol Head Neck Surg 132, 771-778 (2006) DOI: 10.1001/archotol.132.7.771 PMid:16847188
36. Wang, S.J.; Bourguignon, L.Y. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer Arch Otolaryngol Head Neck Surg 132, 19-24 (2006) DOI: 10.1001/archotol.132.1.19 PMid:16415424
37. Bourguignon, L.Y.; Wong, G.; Earle, C.; Chen, L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287, 32800-32824 (2012) DOI: 10.1074/jbc.M111.308528 PMid:22847005 PMCid:PMC3463333
38. Yang, X.H.; Feng, Z.E.; Yan, M.; Hanada, S.; Zuo, H.; Yang, C.Z.; Han, Z.G.; Guo, W.; Chen, W.T.; Zhang, P. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer. PLoS One 7, 31601 (2012) DOI: 10.1371/journal.pone.0031601 PMid:22403616 PMCid:PMC3293890
39. Lee, J.; Jiffar, T.; Kupferman, M.E. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma. PLoS One 7, 30246 (2012) DOI: 10.1371/journal.pone.0030246 PMid:22276165 PMCid:PMC3262811
40. Sun, S.; Wang, Z. Head neck squamous cell carcinoma c-Met(+) cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. Int J Cancer 129, 2337-2348 (2011) DOI: 10.1002/ijc.25927 PMid:21225626
41. Siddique, H.R.; Saleem, M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 30, 372-378 (2012) DOI: 10.1002/stem.1035 PMid:22252887
42. Yu, C.C.; Chen, Y.W.; Chiou, G.Y.; Tsai, L.L.; Huang, P.I.; Chang, C.Y.; Tseng, L.M.; Chiou, S.H.; Yen, S.H.; Chou, M.Y.; Chu, P.Y.; Lo, W.L. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol 47, 202-210 (2011) DOI: 10.1016/j.oraloncology.2010.12.001 PMid:21292542
43. Ginestier, C.; Hur, M.H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C.G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M.S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555-567 (2007) DOI: 10.1016/j.stem.2007.08.014 PMid:18371393 PMCid:PMC2423808
44. Clay, M.R.; Tabor, M.; Owen, J.H.; Carey, T.E.; Bradford, C.R.; Wolf, G.T.; Wicha, M.S.; Prince, M.E. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32, 1195-1201 (2010) DOI: 10.1002/hed.21315 PMid:20073073 PMCid:PMC2991066
45. Reuschenbach, M.; Waterboer, T.; Wallin, K.L.; Einenkel, J.; Dillner, J.; Hamsikova, E.; Eschenbach, D.; Zimmer, H.; Heilig, B.; Kopitz, J.; Pawlita, M.; Doeberitz, M.K.; Wentzensen, N. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPVassociated cancers Int J Cancer 123, 2626-2631 (2008) DOI: 10.1002/ijc.23837 PMid:18785210
46. Wang, S.S.; Hildesheim, A. Chapter 5: Viral and host factors in human papillomavirus persistence and progression J Natl Cancer Inst Monogr 31, 35-40 (2003) DOI: 10.1093/oxfordjournals. jncimonographs.a003480 PMid:12807943
47. Wittekindt, C.; Wagner, S.; Mayer, C.S.; Klussmann, J.P. Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer Laryngorhinootologie 91, 1-26 (2012) NO DOI found
48. Bourguignon, L.Y.; Earle, C.; Wong, G.; Spevak, C.C.; Krueger, K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells Oncogene 31, 149-60 (2012) DOI: 10.1038/onc.2011.222 PMid:21685938 PMCid:PMC3179812
49. Lee, M.J.; Ye, A.S.; Gardino, A.K.; Heijink, A.M.; Sorger, P.K.; MacBeath, G.; Yaffe, M.B. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks Cell 149, 780-794 (2012) DOI: 10.1016/j.cell.2012.03.031 PMid:22579283 PMCid:PMC3501264
50. Abhold, E.L.; Kiang, A.; Rahimy, E.; Kuo, S.Z.; Wang-Rodriguez, J.; Lopez, J.P.; Blair, K.J.; Yu, M.A.; Haas, M.; Brumund, K.T.; Altuna, X.; Patel, A.; Weisman, R.A.; Ongkeko, W.M. EGFR kinase promotes acquisition of stem celllike properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells. PLoS One 7, 32459 (2012) DOI: 10.1371/journal.pone.0032459 PMid:22384257 PMCid:PMC3288103
51. Zhang, M.; Singh, R.K.; Wang, M.H.; Wells, A.; Siegal, G.P. Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44. Clin Exp Metastasis 14, 268-276 (1996) PMid:8674281 NO DOI found
52. Posner M; Lorche J; Goloubeva O; Tan M, Schumaker L.M.; Sarlis N.J.; Haddad R.I.; Cullen K.J. Survival and human papillomavirus in oropharynx cancer in TAX324: a subset analysis from an international phase III trial. Ann Oncol 22, 1071-1077 (2011) DOI: 10.1093/annonc/mdr006 PMid:21317223
53. Ang K.K; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman C.C; Redmond K.P; Gillison M.L Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363, 24-35 (2010) DOI: 10.1056/NEJMoa0912217 PMid:20530316 PMCid:PMC2943767
54. Butz K; Geison C; Ullmann A, Spitkovsky D; Hoppe-Seyler. F Cellular responses of HPV-positive cancer cells to genotoxic anticancer agents: repression of E6/E6 oncogene expression and induction of apoptosis. Int J Cancer 68, 506-513 (1996) DOI: 10.1002/(SICI)1097-0215(19961115)68:4〈506::AID-IJC17〉3.0.CO;2-2